Académique Documents
Professionnel Documents
Culture Documents
Case Introduction
Pt. Data
Physical Assessment
Normal values
Outcome
Interpretation
Axillary temp
37C
36.7
Normal
Respiratory rate
12-20bpm
18bpm
Normal
Pulse rate
60-100bpm
84bpm
Normal
BP
120/80mmHg
130/60
Axillary temp
Normal values
Outcome
Interpretation
37C
36.7
Respiratory rate
12-20bpm
18bpm
Normal
Pulse rate
60-100bpm
84bpm
Normal
BP
120/80mmHg
130/60
Nose
Laboratory Test
06/16/13
Result
Normal Values
Interpretation
RBC
4.0
4-6X10 12/1
Normal
Hemoglobin
131 g/l
M: 130-180 g/l
F: 120-160 g/l
Normal
Hematocrit
0.42 g/l
M: 0.40-0.54
F: 0.36-0.47
Normal
B.T (Dukes)
None
1-4 mins
Normal
C.T. (Slide)
None
2-5 mins.
Normal
Platelet
400
150-400x10 9/L
Normal
06/16/13
WBC
Result
Normal Values
Interpretation
9.0
4-11x10 9/L
Normal
Segmenters
75
50-70
There's a
presence infection
Lymphocytes
24
25-40
Slightly decrease
Monocytes
0-8
Normal
Eosinophils
0-4
Normal
Stab
None
0-3
Basophils
None
0-2
Others
None
Blood Typing
None
Differential Count
Pathophysiology
Environment pollutant
Acute bronchitis
Irritate in airway
Mucous plug the airway
Hypersecretion of
mucous
Inflammation
Narrowing of bronchial
lumen
Clinical Management
Drug Study
Guafenesin/Chloramphenamine
Therapeutic
Effect
Expectorant
Action
Contraindica
tion
Side Effects
Intervention
GI
discomfort,
nausea and
vomiting;
dizziness,
drowsiness,
headache;
rash;
decreased
uric acid
levels;
urinary
calculi (large
doses).
WARNING:
Monitor
reaction to
drug;
persistent
cough for
more than 1
wk, fever,
rash, or
persistent
headache
may indicate
a more
serious
condition.
Dosage
5ml TID
Salbutamol
Therapeutic
Effect
Antiasthmatic
and COPD
preparation
Action
Contraindicatio
n
Side Effects
It relieves nasal
congestion and
reversible
bronchospasm by
relaxing
the smooth
muscles of the
bronchioles.
Hypersensitivity
to adrenergic am
inesHypersensitivity
to fluorocarbons
1.Nervousness
2.Restlessness
3. Tremor
4. Headache
5. Insomnia6
. Chest pain
7.
Palpitations
8. Angina\
9. Arrhythmias10
Hypertension11
\S. Nausea and v
omiting
12.
Hyperglycemia
13. Hypokalemia
Intervention
Dosage
5 ml TID
Cardiac disease i
ncluding coronar
y insufficiency, a
history of stroke
, coronary artery
disease and
cardiac
arrhythmias
Therapeutic
Effect
Paracetamol
Classification
Anti-pyretic
Action
Contraindication
Decreases fever by
(1) hypothalmic
effect leading to
sweating and
vasodilation
(2) inhibits the
effects of pyrogens
on the hypothalamic
heat regulating
centers.
Renal insufficiency,
anemia, liver
failures. Clients
with cardiac or
pulmonary disease
are more susceptible
to toxicity
Side Effects
Intervention
Dosage
Contraindicated in
patients
hypersensitive to
drug.
Use cautiously in
patients with long
term alcohol use
because therapeutic
doses cause
hepatotoxicity in
these patients.
In children, dont
exceed five doses in
24 hours.
Hematologic:
hemolytic anemia,
neutropenia,
leucopenia,
pancytopenia.
Hepatic: Jaundice
Metabolic:
Hypoglycemia
Skin: rash, urticaria.
Assessment
Diagnosis
Planning
Intervention
Rationale
Evaluation
Subjective:
Nahihiripan ako
huminga as
verbalized by the
patient
Ineffective airway
clearance related
to obstruction by
secretion due to
excessive
production
After 8 hours of
nursing
intervention the
patient will
maintain airway
patency
Serves as baseline
data
After 8 hours of
nursing
intervention the
patient maintained
airway patency
Objective:
Positive
productive cough
Positive
crackles
Positive of
difficulty of
breathing
Slightly in
distress
Restless
irritable
To facilitate
maximum lung
expansion
Avoid exposure to
irritants such as
cigarette smoke,
aerosol and fumes
To avoid allergic
reaction
Auscultate breath
sounds
To as certain status
and note progress
Helps liquefy
secretions
Suction as ordered
To clear airway
Provide oxygen
inhalation as ordered
Administer
medication as ordered
Encourage the
opportunities for rest;
limit activities to
level of respiratory
tolerance
Provide adequate
amount of oxygen
Will help loosen
secretions for easy
expulsion.
Prevents or reduces
fatigue